UNII H77VEI93A8

FD&C YELLOW NO. 6

Unique Ingredient Identifier H77VEI93A8 is listed as a ingredient substance
UniiH77VEI93A8
Preferred Substance NameFD&C YELLOW NO. 6
Rn2783-94-0
Ec220-491-7
NcitC71636
Rxcui1305574
Molecular FormulaC16H10N2O7S2.2Na
InchikeyOIQPTROHQCGFEF-QIKYXUGXSA-L
Smiles[Na+].[Na+].OC1=CC=C2C=C(C=CC2=C1\N=N\C3=CC=C(C=C3)S([O-])(=O)=O)S([O-])(=O)=O
Unii TypeINGREDIENT SUBSTANCE
RN2783-94-0
EC220-491-7
NCITC71636
RXCUI1305574
MFC16H10N2O7S2.2Na
INCHI KEYOIQPTROHQCGFEF-QIKYXUGXSA-L
SMILES[Na+].[Na+].OC1=CC=C2C=C(C=CC2=C1\N=N\C3=CC=C(C=C3)S([O-])(=O)=O)S([O-])(=O)=O

Alternate Names

Dosage Forms

UNII H77VEI93A8 FD&C YELLOW NO. 6 is commonly included in medications in the following forms.

RouteDosage FormPotency
INHALATIONPOWDER0.12 MG
INHALATIONSOLUTION NA
ORALCAPSULE0.96 MG
ORALCAPSULE (IMMED./COMP. RELEASE), SOFT GELATIN, PERL NA
ORALCAPSULE, COATED PELLETS0.002 MG
ORALCAPSULE, DELAYED ACTION0.07 MG
ORALCAPSULE, DELAYED ACTION, ENTERIC COATED NA
ORALCAPSULE, ENTERIC COATED PELLETS0.028 MG
ORALCAPSULE, EXTENDED RELEASE0.91 mg
ORALCAPSULE, HARD GELATIN0.001 MG
ORALCAPSULE, SOFT GELATIN0.8 MG
ORALCAPSULE, SOFT GELATIN LIQUID-FILLED0.13 MG
ORALCAPSULE, SUSTAINED ACTION4.59 MG
ORALCONCENTRATE0.03 MG/5ML
ORALDROPS NA
ORALLIQUID0.006 MG/5ML
ORALPOWDER20 MG/1PKT
ORALPOWDER, FOR ORAL SUSPENSION0.65 MG/5ML
ORALPOWDER, FOR RECONSTITUTION NA
ORALPOWDER, FOR SOLUTION4 MG
ORALPOWDER, FOR SUSPENSION2 MG/5ML
ORALSOLUTION75.3 MG/15ML
ORALSOLUTION3.54 mg
ORALSOLUTION1.8 mg/15 mL
ORALSOLUTION, ELIXIR4 %
ORALSUSPENSION5 MG/5ML
ORALSUSPENSION, EXTENDED RELEASE0.12 MG/5ML
ORALSUSPENSION, LIQUID0.01 %
ORALSUSPENSION, SUSTAINED ACTION0.11 MG/5ML
ORALSYRUP0.95 %
ORALTABLET60.02 MG
ORALTABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE0.3 MG
ORALTABLET, CHEWABLE0.03 MG
ORALTABLET, COATED3.17 MG
ORALTABLET, DELAYED ACTION1.5 mg
ORALTABLET, DELAYED ACTION, ENTERIC COATED0.019 MG
ORALTABLET, EXTENDED RELEASE2.87 MG
ORALTABLET, FILM COATED1 MG
ORALTABLET, ORALLY DISINTEGRATING1.36 MG
ORALTABLET, REPEAT ACTION0.02 MG
ORALTABLET, SUSTAINED ACTION1.06 MG
RECTALSOLUTION0.5 %
SUBLINGUALFILM0.02 MG
SUBLINGUALTABLET0.4 MG
TOPICALEMULSION, CREAM NA
TOPICALGEL0.001 %W/W
TOPICALLOTION0.002 %W/W
TOPICALSPONGE NA

© 2020 FDA.report
This site is not affiliated with or endorsed by the FDA.